Home › Calculator › MLYS Dividend Calculator 2026
MLYS Dividend Calculator 2026
No dividendHealthcareMineralys Therapeutics, Inc. · NASDAQ
Price: $20.45 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
Calculator settings
MLYS is not a dividend-focused stock
MLYS pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
MLYS Dividend Yield
Mineralys Therapeutics, Inc. (MLYS) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When MLYS pays your bills
Year your monthly dividend income covers each expense (based on current settings)
About Mineralys Therapeutics, Inc. (MLYS) — Dividend Analysis 2026
Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Its clinical-stage product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that are initially developing for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease. The company was founded by Brian Taylor Slingsby on May 31, 2019 and is headquartered in Radnor, PA.
MLYS Dividend & DRIP — Frequently Asked Questions
Does MLYS pay a dividend?
No. Mineralys Therapeutics, Inc. (MLYS) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
How can I get dividend income instead of MLYS?
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
Does MLYS have a DRIP (dividend reinvestment plan)?
A DRIP reinvests dividends into new shares. MLYS has no regular dividend in our data, so there is nothing to reinvest.
Stocks similar to MLYS
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full MLYS DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open MLYS position with:
🌍 MLYS Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold MLYS.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 MLYS Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 MLYS Dividend Payment Schedule
MLYS pays quarterly — 4 times per year. Ex-div: —.
📊 MLYS vs Healthcare Benchmarks
How MLYS compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for MLYS sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ MLYS Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-10-19 | 16,600 | $20.92 | $347.3K | ||
| A-Award | 2026-10-19 | 12,400 | — | — | ||
| A-Award | 2026-10-19 | 16,600 | $20.92 | $347.3K | ||
| A-Award | 2026-10-19 | 12,400 | — | — | ||
| Sale | 2026-09-30 | 75,000 | $25.46 | $1.91M | ||
| Sale | 2026-09-22 | 104,320 | $28.81 | $3.01M | ||
| M-Exempt | 2026-09-21 | 7,438 | $13.24 | $98.5K | ||
| M-Exempt | 2026-09-21 | 7,438 | $13.24 | $98.5K | ||
| Sale | 2026-09-21 | 7,438 | $28.12 | $209.1K | ||
| M-Exempt | 2026-09-15 | 3,000 | $12.02 | $36.1K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Peer Group
Similar companies in the same sectorCompare MLYS with peers: MLYS vs DMAC · MLYS vs MAZE · MLYS vs OBIO
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the MLYS dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Mineralys Therapeutics, Inc. (MLYS) is currently trading at $20.45, trading near its 52-week low. It does not currently pay a regular dividend.
Does MLYS Pay a Dividend? Mineralys Therapeutics, Inc. Dividend Status
Mineralys Therapeutics, Inc. (MLYS) is a healthcare stock trading at $20.45. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
- Without a dividend, returns depend entirely on the share price.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest MLYS News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.
Projected your MLYS DRIP returns?
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.